Moneycontrol
HomeNewsIndiaBlack fungus: MP govt to conduct nasal endoscopy of COVID-19 patients
Trending Topics

Black fungus: MP govt to conduct nasal endoscopy of COVID-19 patients

This campaign is aimed at the early detection and treatment of mucormycosis, a rare but dangerous fungal infection.

May 19, 2021 / 15:15 IST
Story continues below Advertisement

Mucormycosis (known as black fungus), a rare life-threatening infection that’s being reported in some COVID-19 patients. (Image: News18 Creative)

The Madhya Pradesh government has decided to launch the "nasal endoscopy" campaign in view of the rise in the cases of mucormycosis or black fungus in COVID-19 patients, state Medical Education Minister Vishvas Kailash Sarang said on Wednesday.

This campaign is aimed at the early detection and treatment of mucormycosis, a rare but dangerous fungal infection.

Story continues below Advertisement

"Given the rise in the cases of mucormycosis in COVID-19 patients, we have decided to launch the nasal endoscopy campaign for the early detection and treatment of the disease at the primary level only," a public relations department official said quoting Sarang.

He said the government will conduct the nasal endoscopy of COVID-19 patients as well as those COVID-19 survivors who are admitted in the district hospitals and the government medical colleges in the last two months for free.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show